Richard Harris, NPR; When Scientists Develop Products From Personal Medical Data, Who Gets To Profit?
"If you go to the hospital for medical treatment and scientists there
decide to use your medical information to create a commercial product,
are you owed anything as part of the bargain?
That's one of the
questions that is emerging as researchers and product developers
eagerly delve into digital data such as CT scans and electronic medical
records, making artificial-intelligence products that are helping
doctors to manage information and even to help them diagnose disease.
This
issue cropped up in 2016, when Google DeepMind decided to test an app
that measures kidney health by gathering 1.6 million records from
patients at the Royal Free Hospital in London. The British authorities
found this broke patient privacy laws in the United Kingdom. (Update on June 1 at 9:30 a.m. ET: DeepMind says it was able to deploy its app despite the violation.)
But the rules are different in the United States."
Issues and developments related to IP, AI, and OM, examined in the IP and tech ethics graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology", coming in Summer 2025, includes major chapters on IP, AI, OM, and other emerging technologies (IoT, drones, robots, autonomous vehicles, VR/AR). Kip Currier, PhD, JD
Showing posts with label commercial medical products developed from personal medical data. Show all posts
Showing posts with label commercial medical products developed from personal medical data. Show all posts
Subscribe to:
Posts (Atom)